DM199

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)NCT04123613DMACPhase 2Completed2022-03-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.